Skip to main navigation Skip to search Skip to main content

SAR: IpY, a novel peptide inhibitor for ER/PR+, HER2-breast cancer

Project: Research

Project Details

StatusFinished
Effective start/end date10/20/1708/31/18

Funding

  • Concarlo Holdings LLC: $13,770.00